Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $5.9200 (-2.15%) ($5.9200 - $5.9200) on Wed. Sep. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.15% (three month average) | RSI | 34 | Latest Price | $5.9200(-2.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(70%) ARKK(68%) IWO(65%) IBUY(64%) | Factors Impacting CGEN price | CGEN will decline at least -1.575% in a week (0% probabilities). VIXM(-52%) VXX(-38%) UUP(-13%) TLT(-6%) SHY(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.575% (StdDev 3.15%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.59(-177.53%) | Resistance Level | $6.46 | 5 Day Moving Average | $6.15(-3.74%) | 10 Day Moving Average | $6.22(-4.82%) | 20 Day Moving Average | $6.46(-8.36%) | To recent high | -29.1% | To recent low | 1.9% | Market Cap | $490m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |